AKERO THERAPEUTICS INC's ticker is and the CUSIP is 00973Y908. A total of 5 filers reported holding AKERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,006,208 | +724.2% | 217,600 | +660.8% | 0.00% | – |
| Q2 2023 | $1,335,334 | -71.6% | 28,600 | -76.7% | 0.00% | -100.0% |
| Q1 2023 | $4,694,502 | -32.7% | 122,700 | -3.6% | 0.00% | -33.3% |
| Q4 2022 | $6,976,040 | +87.3% | 127,300 | +16.4% | 0.00% | +50.0% |
| Q3 2022 | $3,725,000 | – | 109,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 45,100 | $1,536,000 | 0.00% |
| JANE STREET GROUP, LLC | 109,400 | $3,725,000 | 0.00% |
| SIMPLEX TRADING, LLC | 29,500 | $1,004,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |